Antiviral therapy of hepatitis C — present and future
Authors:
- Adrian M. Di BisceglieABAdrian M. Di Bisceglie
- Michiko ShindoMSMichiko Shindo
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 17, S130-S136
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from FranceHepatology, 1991
- Recombinant human interferon alfa-2a in community-acquired non-A, non-B chronic active hepatitis. Preliminary results of a randomized, controlled trialJournal of Hepatology, 1990
- Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experienceJournal of Hepatology, 1990
- One-year treatment of chronic non-A, non-B hepatitis with interferon alfa-2bJournal of Hepatology, 1990
- Prolonged treatment (18 months) of chronic hepatitis C with recombinant α-interferon in comparison with a control groupJournal of Hepatology, 1990
- A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitisJournal of Hepatology, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis.BMJ, 1989
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986